Sophia Genetics SA (SOPH) Social Stream

Sophia Genetics SA (SOPH): $11.59

-0.32 (-2.69%)

POWR Rating

Component Grades













SOPHiA GENETICS SA (SOPH) Price Targets From Analysts

Use the tables below to see what analysts covering SOPHiA GENETICS SA think about its future price and what recommendations they have for investors and traders.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
3 $23 $23 $23 $13.18 74.51%
3 $24 $23 $23.5 $13.18 78.3%

SOPH reports an average of 30.15% for its upside potential over the past 75 days.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-11-11 3 23 23 23 15.57 47.72%
2021-08-28 NA 24 22 23 19.00 21.05%

SOPH Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.17 2 1 0 0 0 3

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • SOPHiA GENETICS SA's variance in analysts' estimates is lower than 90.94% of all US stocks.
  • To contextualize these metrics, consider that out of Technology stocks, SOPHiA GENETICS SA's number of analysts covering the stock is greater than 20.2% of them.
  • In terms of how SOPHiA GENETICS SA fares relative to Technology stocks, note that its average analyst price target is greater than 48.3% of that group.
  • SOPH has a higher upside potential (average analyst target price relative to current price) than 62.26% of Pharmaceutical Products stocks.

In the Pharmaceutical Products industry, DNA, EVO and THRN are the three stocks most similar to SOPHiA GENETICS SA regarding the price target and analyst recommendation information presented here.

What is the outlook for SOPH? Use POWR Ratings for clearer insight into price direction.

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7072 seconds.